Patent · US Active

CCR7 ligand delivery and co-delivery in immunotherapy

US8592364B2 · kind B2 · utility

26Cited by

35References

26Claims

0Family size

Assignee

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) · CH

Inventors

Melody Swartz · Chicago, US
Jeffrey A. Hubbell · Austin, US
Alice Tomei · Lausanne, CH
Jacqueline Shields · Nice, FR
Iraklis Kourtis · Arlington, US

Key dates

Filing date	Feb 10, 2011
Grant date	Nov 26, 2013
Priority date	—
Expiry date	Feb 10, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/15052
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Chemokines may be administered to a patient for immunotolerization. Chemokines include CCL19 and CCL21. Materials and methods for accomplishing tolerization and described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.